Clavis Pharma Asa
USPTO Trademark & Patent Filings
Trademark applications and grants for Clavis Pharma Asa. Clavis Pharma Asa has 9 trademark applications. The latest application filed is for "MAJENSA"
- Company Aliases
- Clavis Pharma ASA
- asa pharma clavis
- CLAVIS PHARMA ASA - Oslo NO
- CLAVIS PHARMA ASA - Olso NO
- Clavis Pharma ASA - Oslo NO
Trademarks Patents
| Patent Application | Date |
|---|---|
| PARENTERAL FORMULATIONS OF ELACYTARABINE DERIVATIVES 20130196941 - 13/809653 Ahrabi; Sayeh ; et al. | 2013-08-01 |
| Methods and Compositions for Treating or Ameliorating Cancer Using Gemcitabine-5'-Elaidate 20130005678 - 13/583982 Sandvold; Marit Liland ; et al. | 2013-01-03 |
| FATTY ACID ESTERS OF GLUCOCORTICOIDS AS ANTI-INFLAMMATORY AND ANTI-CANCER AGENTS 20100099654 - 12/531214 Finn; Myhren ; et al. | 2010-04-22 |
| Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents 9,428,540 - 12/531,214 Myhren , et al. August 30, 2 | 2016-08-30 |
| Parenteral formulations of elacytarabine derivatives 8,912,162 - 13/809,653 Ahrabi , et al. December 16, 2 | 2014-12-16 |
| Azacytidine analogues and uses thereof 8,399,420 - 12/238,054 Silverman , et al. March 19, 2 | 2013-03-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 